BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 17768807)

  • 1. Resolution of equivocal results with the Hybrid Capture II high-risk HPV DNA test: a cytologic/histologic review of 191 cases.
    Knoepp SM; Kuebler DL; Wilbur DC
    Diagn Mol Pathol; 2007 Sep; 16(3):125-9. PubMed ID: 17721319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-risk human papillomavirus DNA testing: a marker for atypical glandular cells.
    Saqi A; Gupta PK; Erroll M; Babiac A; Blackmun D; Mansukhani M; Vazquez M
    Diagn Cytopathol; 2006 Mar; 34(3):235-9. PubMed ID: 16470857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Usefulness of HPV test on cell sample from the cervix].
    Vintermyr OK; Skar R; Iversen OE; Haugland HK
    Tidsskr Nor Laegeforen; 2008 Jan; 128(2):171-3. PubMed ID: 18202727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of cytological test for cervices to identify human papillomavirus in the screening program on serious cervical lesion].
    Wang GP; Li RZ; Wu LN; Li J; Liu ZH; Wang C; Zhou YQ; Weng LM; Wu RF
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Jun; 30(6):626-30. PubMed ID: 19957634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
    Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
    BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subvisual chromatin changes in cervical epithelium measured by texture image analysis and correlated with HPV.
    Guillaud M; Adler-Storthz K; Malpica A; Staerkel G; Matisic J; Van Niekirk D; Cox D; Poulin N; Follen M; Macaulay C
    Gynecol Oncol; 2005 Dec; 99(3 Suppl 1):S16-23. PubMed ID: 16188299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus detection: verification with cervical cytology.
    Matthews-Greer J; Rivette D; Reyes R; Vanderloos CF; Turbat-Herrera EA
    Clin Lab Sci; 2004; 17(1):8-11. PubMed ID: 15011974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A peer comparison program for the quality assurance of human papillomavirus DNA detection using the Digene Hybrid Capture II/SurePath method shows excellent analytic interlaboratory correlation.
    Kuebler DL; Illingworth A; Blenc AM; Wilbur DC
    Cancer; 2007 Oct; 111(5):339-43. PubMed ID: 17879373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and risk factors for human papillomavirus DNA in cervical cytology.
    Kasap B; Yetimalar H; Keklik A; Yildiz A; Cukurova K; Soylu F
    Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):168-71. PubMed ID: 21764503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus prevalence in women with normal cytology and with cervical cancer in Natal, Brazil.
    Fernandes JV; Meissner Rde V; Carvalho MG; Fernandes TA; Azevedo PR; de Azevedo JW; de Araújo JM
    Mol Med Rep; 2011; 4(6):1321-6. PubMed ID: 21887467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent human papillomavirus infection detected with the hybrid capture II assay selects women with normal cervical smears at risk for developing high grade cervical lesions: a longitudinal study of 3,091 women.
    Bory JP; Cucherousset J; Lorenzato M; Gabriel R; Quereux C; Birembaut P; Clavel C
    Int J Cancer; 2002 Dec; 102(5):519-25. PubMed ID: 12432556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of liquid-based cytology specimens for the immunocytochemical study of p16 expression and human papillomavirus testing: a comparative study using simultaneously sampled histology materials.
    Yoshida T; Fukuda T; Sano T; Kanuma T; Owada N; Nakajima T
    Cancer; 2004 Apr; 102(2):100-8. PubMed ID: 15098254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study for association between high risk human papillomavirus and cervical lesions in the samples from opportunistic screening].
    Bian LH; Li Y; Wang XL; Wu XZ; Song L; Liu HT
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Apr; 25(2):89-91. PubMed ID: 21863625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Investigation of human papillomavirus DNA in cervical specimens by hybrid capture assay].
    Oztürk S; Kaleli I; Kaleli B; Bir F
    Mikrobiyol Bul; 2004 Jul; 38(3):223-32. PubMed ID: 15490841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Epidemiology of HPV infection].
    Boulanger JC; Sevestre H; Bauville E; Ghighi C; Harlicot JP; Gondry J
    Gynecol Obstet Fertil; 2004 Mar; 32(3):218-23. PubMed ID: 15123119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thin-layer cytology: identification of human papillomavirus by hybridization, capture and signal amplification assay using an alcoholic cell preservative medium.
    Hammou JC
    Acta Cytol; 2007; 51(2):193-6. PubMed ID: 17425201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlation of hybrid II capture cytologic exam in diagnosis of cervical lesions related to HPV].
    Saturnino AC; Diniz VC; Sisenando HA; de Souza EM; de Paiva MS; de Brito MH; Ramos ES
    Acta Cir Bras; 2005; 20 Suppl 1():185-9. PubMed ID: 17768807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus DNA detection in cervical specimens by hybrid capture: correlation with cytologic and histologic diagnoses of squamous intraepithelial lesions of the cervix.
    Hall S; Lörincz A; Shah F; Sherman ME; Abbas F; Paull G; Kurman RJ; Shah KV
    Gynecol Oncol; 1996 Sep; 62(3):353-9. PubMed ID: 8812532
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.